The context of human recombinant insulin is it’s a market within diabetes care industries that focuses on offering artificial insulin to diabetic patients with insulin needs for regulating glucose levels in the blood. Recombinant insulin is man-made insulin made by recombinant DNA technology in which human insulin genes are incorporated into bacteria or yeast cells to synthesize insulin most closely resembling human insulin. This synthetic insulin is more safe, pure and effective than the others, and therefore; it is a crucial medication for all diabetic patients in the world. Owing to a prevalence of diabetes in the world, customers seek the human recombinant insulin to maintain their blood glucose level without developing complications of the diseases.

Hereditary Orotic Aciduria is a rare metabolic disease caused by the OMIM database the UMPS gene inheritance of recessive nature of the pyrimidine biosynthesis de novo pathway, the enzyme deficiency. This enzyme catalyzes the conversion of orotic acid to uridine monophosphate (UMP), which is needed in pyrimidine synthesis; pyrimidines are parts of both DNA and RNA.